Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-16-115339

Director acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CANNON JAMES ANTHONY Director 2016-04-21 Option exercise +15,000 $5.01 $75,150 341,963 D
Derivatives
CANNON JAMES ANTHONY Director 2016-04-21 Option exercise · Stock Option (right to buy) −15,000 0 D
Loading xslF345X03/doc4.xml…